Screening for atrial fibrillation: a European heart rhythm association (EHRA) consensus document endorsed by the heart rhythm Society (HRS), Asia Pacific heart …
GH Mairesse, P Moran, IC Van Gelder, C Elsner… - Ep …, 2017 - academic.oup.com
Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1–2% of the
general population. Its prevalence varies between continents and ethnicity, but the …
general population. Its prevalence varies between continents and ethnicity, but the …
AF burden is important–fact or fiction?
G Boriani, I Diemberger, M Ziacchi… - … journal of clinical …, 2014 - Wiley Online Library
Asymptomatic atrial fibrillation (AF) is common and in view of its prognostic impact (the same
as of clinically overt AF) knowledge of the overall AF burden (defined as the amount of time …
as of clinically overt AF) knowledge of the overall AF burden (defined as the amount of time …
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a …
The kidney exerts multiple functions, and pathophysiological interactions between the
kidney and the heart have important clinical implications, but it has only recently become …
kidney and the heart have important clinical implications, but it has only recently become …
Global health and cardiovascular disease
The modern definition of Global Health has expanded its scope beyond neglected diseases
and low-income and underdeveloped countries. The current initiatives focus on …
and low-income and underdeveloped countries. The current initiatives focus on …
Implant rates of cardiac implantable electrical devices in Europe: a systematic literature review
Background In recent years, indications for cardiac implantable electrical devices (CIEDs)
have broadened; however, budget constraints can significantly impact patient access to …
have broadened; however, budget constraints can significantly impact patient access to …
Cardiac device therapy in patients with left ventricular dysfunction and heart failure:'real‐world'data on long‐term outcomes (mortality, hospitalizations, days alive and …
Background The impact on long‐term outcomes of implantable cardioverter defibrillators
(ICDs) and biventricular defibrillators for cardiac resynchronization (CRT‐D) devices in 'real …
(ICDs) and biventricular defibrillators for cardiac resynchronization (CRT‐D) devices in 'real …
Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy
Background There is evidence that implantable cardioverter‐defibrillator (ICD) for primary
prevention in people with an ischaemic cardiomyopathy improves survival rate. The …
prevention in people with an ischaemic cardiomyopathy improves survival rate. The …
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon
Aims To determine the long-term costs of extending device longevity in four patient
populations requiring a single-chamber implantable cardioverter-defibrillator (ICD) or …
populations requiring a single-chamber implantable cardioverter-defibrillator (ICD) or …
Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular …
GB Forleo, L Di Biase, R Bharmi, N Dalal… - EP …, 2015 - academic.oup.com
Aims This study compares, from a prospective, observational, non-randomized registry, the
post-implant hospitalization rates and associated healthcare resource utilization of cardiac …
post-implant hospitalization rates and associated healthcare resource utilization of cardiac …
Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?
Cardiac resynchronization therapy (CRT) was proposed around 20 years ago, and its
clinical use rapidly moved from pioneering experiences to randomized controlled trials …
clinical use rapidly moved from pioneering experiences to randomized controlled trials …